The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
18 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,158,869 in first-year total cost, median $763,509.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-C (M2)]11
- Special Emphasis Panel[ZCA1 GRB-I (M2)]7
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL1
- CHILDREN'S HOSP OF PHILADELPHIA1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- HARVARD MEDICAL SCHOOL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Notch Signaling in Cancer1R35CA220340-01 | BLACKLOW, STEPHEN C. | HARVARD MEDICAL SCHOOL, MA | $1,010,339 | ZCA1 |
| 2017 | Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer1R35CA220538-01 | SHAW, REUBEN | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $996,270 | ZCA1 |
| 2017 | Metabolic Regulators of Tumor Growth and Progression1R35CA220449-01 | DEBERARDINIS, RALPH J | UT SOUTHWESTERN MEDICAL CENTER, TX | $961,705 | ZCA1 |
| 2017 | Defining Drivers of HPV-associated Carcinogenesis1R35CA210807-01A1 | LAMBERT, PAUL F. | UNIVERSITY OF WISCONSIN-MADISON, WI | $918,000 | ZCA1 |
| 2017 | Tumor Plasticity1R35CA220446-01 | ALTIERI, DARIO C | WISTAR INSTITUTE, PA | $900,000 | ZCA1 |
| 2017 | Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression1R35CA220483-01 | SIMON, M. CELESTE | UNIVERSITY OF PENNSYLVANIA, PA | $899,417 | ZCA1 |
| 2017 | Molecular pathways and targeted therapies in human leukemia1R35CA210065-01A1 | FERRANDO, ADOLFO A. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $849,333 | ZCA1 |
| 2017 | Epi-genetic Programs in Cancer Progression1R35CA220487-01 | WEINBERG, ROBERT A | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $799,440 | ZCA1 |
| 2017 | Novel DNA Repair Inhibitors for Cancer Therapy1R35CA197574-01A1 | GLAZER, PETER M | YALE UNIVERSITY, CT | $773,292 | ZCA1 |
| 2017 | Epigenetic regulation of cellular plasticity and cancer cell fate1R35CA210104-01A1 | SHI, YANG | BOSTON CHILDREN'S HOSPITAL, MA | $753,725 | ZCA1 |
| 2017 | Molecular and immunologic evolution of melanomas from pre-neoplastic lesions1R35CA220481-01 | BASTIAN, BORIS C. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $720,975 | ZCA1 |
| 2017 | Harnessing the power of exosomes for non-coding RNA delivery1R35CA209904-01A1 | SOOD, ANIL K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $704,789 | ZCA1 |
| 2017 | Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy1R35CA220434-01 | WEISSMAN, IRVING L. | STANFORD UNIVERSITY, CA | $693,152 | ZCA1 |
| 2017 | Molecular Imaging and Theranostics of Cancer1R35CA209960-01A1 | BHUJWALLA, ZAVER M. | JOHNS HOPKINS UNIVERSITY, MD | $691,623 | ZCA1 |
| 2017 | Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes1R35CA220500-01 | MARIS, JOHN M | CHILDREN'S HOSP OF PHILADELPHIA, PA | $683,163 | ZCA1 |
| 2017 | Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies1R35CA210084-01A1 | DIPERSIO, JOHN F. | WASHINGTON UNIVERSITY, MO | $661,623 | ZCA1 |
| 2017 | PTEN and Cancer1R35CA220491-01 | PARSONS, RAMON E | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $644,808 | ZCA1 |
| 2017 | Human Papillomavirus and Polyomavirus Associated Malignancies.1R35CA209979-01A1 | GALLOWAY, DENISE A. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $497,215 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.